共 595 条
[51]
Morrow DA(2011)VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruption Investig New Drugs 29 1497-998
[52]
Newby LK(2005)A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer Clin Transl Oncol 7 66-223
[53]
Ornato JP(2010)Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients Int J Urol 17 629-558
[54]
Ou N(2004)Thromboembolic events with estramustine phosphate-based chemotherapy in patients with hormone-refractory prostate carcinoma Cancer 101 2755-2551
[55]
Radford MJ(2013)Risk of ischemic heart disease in women after radiotherapy for breast cancer N Engl J Med 368 987-628
[56]
Tamis-Holland JE(2016)SCAI expert consensus statement: evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory Cathet Cardiovasc Intervent 87 202-1755
[57]
Tommaso CL(2015)Cardiotoxicity of anticancer treatments Nat Rev Cardiol 12 547-1764
[58]
Tracy CM(2017)Cardiovascular complications of Cancer therapy: best practices in diagnosis, prevention, and management—part 1 J Am Coll Cardiol 70 2536-334
[59]
Woo YJ(2020)Reporting of cardiovascular events in clinical trials supporting FDA approval of contemporary cancer therapies J Am Coll Cardiol 75 620-271
[60]
Zhao DX(2016)Fulminant myocarditis with combination immune checkpoint blockade N Engl J Med 375 1749-658